The present invention relates an antibody molecule that binds to human CD37 and that is a chimeric antibody wherein the variable sequences are: a variable heavy chain comprising the amino acid sequence shown in SEQ ID NO: 1 and a variable light chain comprising the amino acid sequence shown in SEQ ID NO :3 (sequences as defined within the specification).